WELLINGTON MANAGEMENT GROUP LLP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,164,963
-0.3%
502,375
-8.7%
0.00%0.0%
Q1 2023$3,175,416
-58.3%
550,332
-25.9%
0.00%
-50.0%
Q4 2022$7,620,512
-52.0%
742,740
-21.7%
0.00%
-33.3%
Q3 2022$15,863,000
+7.0%
948,773
-10.4%
0.00%0.0%
Q2 2022$14,821,000
-8.2%
1,058,649
+6.0%
0.00%0.0%
Q1 2022$16,137,000
-11.9%
999,173
+16.8%
0.00%0.0%
Q4 2021$18,317,000
+30.5%
855,538
-10.5%
0.00%
+50.0%
Q3 2021$14,037,000
-24.0%
955,588
+1.7%
0.00%
-33.3%
Q2 2021$18,472,000
-44.8%
939,362
-17.7%
0.00%
-50.0%
Q1 2021$33,478,0001,141,9850.01%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders